UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000055501
Receipt number R000063416
Scientific Title Further analysis of protein absorption after ingesting an enteral diet
Date of disclosure of the study information 2026/09/01
Last modified on 2024/09/13 17:40:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Further analysis of protein absorption after ingesting an enteral diet

Acronym

Further analysis of protein absorption after ingesting an enteral diet

Scientific Title

Further analysis of protein absorption after ingesting an enteral diet

Scientific Title:Acronym

Further analysis of protein absorption after ingesting an enteral diet

Region

Japan


Condition

Condition

Healthy male adults

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This purpose of this study is further analysis of protein absorption after ingesting an enteral diet (UMIN00049118), to compare the amino acids metabolites .

Basic objectives2

Others

Basic objectives -Others

metabolite analysis

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Concentration of amino acids metabolites in blood

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

35 years-old >

Gender

Male

Key inclusion criteria

Subjects who joined post study (UMIN00049118) and give informed consent to participate in this further analysis.

Key exclusion criteria

No setting

Target sample size

16


Research contact person

Name of lead principal investigator

1st name Yoshitaka
Middle name
Last name Kawai

Organization

Meiji Co., Ltd.

Division name

Nutrition Development Research Unit, R&D Division

Zip code

192-0919

Address

1-29-1 Nanakuni, Hachioji, Tokyo , Japan

TEL

042-632-5810

Email

yoshitaka.kawai@meiji.com


Public contact

Name of contact person

1st name Kazuji
Middle name
Last name Tamura

Organization

Meiji Co., Ltd

Division name

Nutrition Development Research Unit, R&D Division

Zip code

192-0919

Address

1-29-1 Nanakuni, Hachioji, Tokyo, Japan

TEL

042-632-5810

Homepage URL


Email

kazuji.tamura@meiji.com


Sponsor or person

Institute

Meiji Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Meiji Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Chiyoda Paramedical Care Clinic

Address

2F Daiwa Building, 3-3-10 Nihonbashi-Hongoku-Cho, Chuo-ku, Tokyo 103-0021, Japan

Tel

03-6225-9005

Email

IRB@cpcc.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 08 Month 19 Day

Date of IRB

2024 Year 08 Month 16 Day

Anticipated trial start date

2024 Year 09 Month 20 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Compare the amino acids metabolites


Management information

Registered date

2024 Year 09 Month 13 Day

Last modified on

2024 Year 09 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063416